To Evaluate the Effect of Chronic Obstructive Pulmonary Disease on Retinal and Choroidal Thicknesses Measured by Optical Coherence Tomography

Basit Öğe Kaydı
dc.contributor.authorAlim, Sait
dc.contributor.authorDemir, Helin Deniz
dc.contributor.authorYilmaz, Ayse
dc.contributor.authorDemir, Selim
dc.contributor.authorGunes, Alper
dc.date.accessioned2021-11-01T15:02:04Z
dc.date.available2021-11-01T15:02:04Z
dc.date.issued2019
dc.department[Belirlenecek]
dc.description18th Congress of the European-Society-of-Retina-Specialists (EURETINA) -- SEP 20-23, 2018 -- Vienna, AUSTRIA
dc.description.abstractPurpose. To evaluate the retinal and choroidal thicknesses in patients with chronic obstructive pulmonary disease using optical coherence tomography. Methods. The study included 26 patients with chronic obstructive pulmonary disease (COPD) and 26 age-matched healthy control groups. Detailed ocular examinations were performed on all participants. Cirrus EDI-OCT (enhanced depth imaging-optical coherence tomography) was used for choroidal thickness measurements with frame enhancement software. The subfoveal area was used for choroidal thickness measurements. Results. The patients with the chronic obstructive pulmonary disease had an average 239.13 +/- 57.77 mu m subfoveal choroidal thickness, and the control group had an average 285.02 +/- 25 mu m subfoveal choroidal thickness. The subfoveal choroidal thickness measurements revealed a statistically significant difference between patients and the control group (p < 0.05). Were were no statistically significant differences between patients and control group regarding mean macular thickness, central macular thickness, and GCIPL (ganglion cell-inner plexiform layer) thickness. Also, there was no statistically significant difference between patients and control group regarding mean, superior, nasal, inferior, and temporal RNFL (retinal nerve fiber layer) thicknesses. Conclusion. Chronic hypoxemia seems to cause decreased choroidal thickness in patients with chronic obstructive pulmonary disease.
dc.description.sponsorshipEuropean Soc Retina Specialistsen_US
dc.identifier.doi10.1155/2019/7463815
dc.identifier.issn2090-004X
dc.identifier.issn2090-0058
dc.identifier.pmid31687202
dc.identifier.scopus2-s2.0-85074222568
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1155/2019/7463815
dc.identifier.urihttps://hdl.handle.net/11491/6828
dc.identifier.volume2019en_US
dc.identifier.wosWOS:000493019600001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthor[Belirlenecek]
dc.language.isoen
dc.publisherHindawi Ltd
dc.relation.ispartofJournal Of Ophthalmology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject[No Keywords]en_US
dc.titleTo Evaluate the Effect of Chronic Obstructive Pulmonary Disease on Retinal and Choroidal Thicknesses Measured by Optical Coherence Tomography
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu